Cramer says the market can't broaden out due to uncertainty away from tech

  • 📰 CNBC
  • ⏱ Reading Time:
  • 33 sec. here
  • 23 min. at publisher
  • 📊 Quality Score:
  • News: 89%
  • Publisher: 72%

Jim Cramer Nouvelles

Stock Markets,Investment Strategy,Business

CNBC's Jim Cramer said tech stocks have been integral to the market rally, and other sectors can't say the same.

CNBC's Jim Cramer on Thursday said tech stocks have been integral to the market rally, and other sectors can't quite say the same.on Thursday said it's no secret that the market rally has been driven by a handful of tech stocks, and it's not likely to change anytime soon.that beat analysts' estimates and announced a 10-for-1 stock split. It's also one of the companies benefitting from the artificial intelligence boom, Cramer added.

But while tech stocks have been shining, Cramer said other sectors can't quite say the same. It means the market might not be able to broaden out in the manner that many investors are hoping for. For instance, Cramer pointed to the banks, which often serve as a bellwether for the market. He said this sector has been producing solid gains since last year when the Federal Reserve declared there would be no further tightening, but that streak ended whenThose are the largest sectors in decline, though Cramer said he could have widened his net further. It's hard to know where the market would be without the tech sector, he added.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 12. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030AstraZeneca CEO Pascal Soriot discussed his company’s ambitious revenue goal with CNBC’s Jim Cramer.
La source: NBCLA - 🏆 319. / 59 Lire la suite »

Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030AstraZeneca CEO Pascal Soriot discussed his company’s ambitious revenue goal with CNBC’s Jim Cramer.
La source: NBCNewYork - 🏆 270. / 63 Lire la suite »